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ABSTRACT 20 
 21 
Benz[j]aceanthrylene (B[j]A) is a cyclopenta-fused polycyclic aromatic hydrocarbon with 22 
strong mutagenic and carcinogenic effects. We have identified B[j]A in air particulate matter 23 
in samples collected in Stockholm, Sweden and in Limeira, Brazil using LC-GC/MS analysis. 24 
Determined concentrations ranged between 1.57-12.7 and 19.6-30.2 pg/m3 in Stockholm and 25 
Limeira, respectively, which was 11-30 times less than benzo[a]pyrene (B[a]P) 26 
concentrations. Activation of the DNA damage response was evaluated after exposure to 27 
B[j]A in HepG2 cells in comparison to B[a]P. We found that significantly lower 28 
concentrations of B[j]A was needed for an effect on cell viability compared to B[a]P and 29 
equimolar exposure resulted in significant more DNA damage with B[j]A. Additionally, 30 
levels of γH2AX, pChk1, p53, pp53 and p21 proteins were higher in response to B[j]A than 31 
B[a]P. Based on dose response induction of pChk1 and γH2AX, B[j]A potency was 12.5 and 32 
33.3 higher than B[a]P, respectively. Although B[j]A levels in air were low, including B[j]A 33 
in the estimation of excess lifetime cancer risk increased the risk up to 2-fold depending on 34 
which potency factor for B[j]A was applied. Together our results show that B[j]A could be an 35 
important contributor to the cancer risk of air PM. 36 
  37 
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INTRODUCTION 38 
 39 
Particulate matter (PM) from urban air contains a mixture of different chemicals that can 40 
interact and cause adverse effects to human health. Outdoor air pollution and its PM 41 
component have been classified as carcinogenic to humans by IARC.1 One group of 42 
chemicals that are found in air PM is the polycyclic aromatic hydrocarbons (PAHs), 43 
ubiquitous environmental contaminants that are formed during incomplete combustion of 44 
organic matter. PAHs in the environment are of concern because of their carcinogenic 45 
activity and several individual and mixtures of PAHs have been classified as possible or 46 
probable carcinogens to humans .2 To date, benzo[a]pyrene (B[a]P) is the only individual 47 
PAH classified as carcinogenic to humans by IARC.2  48 
 49 
 Health risk assessment of PAH mixtures is often carried out using B[a]P for comparison as 50 
its toxicological profile has been extensively characterized. One approach to perform risk 51 
assessment is based on additivity of toxic equivalency factors (TEFs) or relative potency 52 
factors (RPFs) where the carcinogenic potential is expressed relative to B[a]P.3 A second 53 
method is to use B[a]P as a surrogate marker for all PAHs. This has been applied to air4 and 54 
the European Commission Air Quality Standards has put a target value of PAHs in air 55 
expressed as 1 ng B[a]P/m3 over an exposure period of one year (Directive 2004/107/EC). 56 
However, as has recently been discussed, these risk assessment approaches have limited 57 
application to studying mixture effects and are likely to misestimate the actual risk to human 58 
health.5 Most PAHs have not been assigned TEF/RPF values or their contribution to mixtures 59 
has been overlooked due to a lack of sensitivity in detection methods. This is particularly 60 
applicable to PAHs which are found at low levels in the environment but have demonstrated 61 
high carcinogenic potentials. An example of this is dibenzo[def,p]chrysene (DBC, also 62 
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known as dibenzo[a,l]pyrene), the most potent PAH known to date6-7 yet not included among 63 
the US EPA priority PAHs nor routinely used as an indicator of carcinogenic PAHs.3,8-9 64 
Recent studies have suggested however that the quantification of DBC in urban air has 65 
become more common as a result of improved detection methods.10-14 For the reasons stated 66 
above it is important to analyze and determine the levels of PAHs with high carcinogenic 67 
potential in environmental samples to include them in the evaluation of mixture exposure 68 
risks. 69 
 70 
One poorly studied PAH that has shown high carcinogenic potential is benz[j]aceanthrylene 71 
(B[j]A).15-16 B[j]A is a cyclopenta-fused and bay-region containing PAH. As with other 72 
PAHs B[j]A requires metabolic activation in order to exert is biological activity and studies 73 
have identified two major routes of activation: epoxidation of the cyclopenta-ring, resulting 74 
in the B[j]A-1,2-epoxide, and diol-epoxidation of the bay-region, resulting in the B[j]A-9,10-75 
diol-7,8-epoxide.15,17-18 The former is the major metabolite found as a 1,2-diol in human and 76 
rat liver tissues and cells.19-20 B[j]A is a potent bacterial and mammalian cell mutagen and is 77 
more tumorigenic than B[a]P in SENCAR mice and in A/J mice lung.15-16 Trace amounts of 78 
B[j]A have been found in the emissions from coal-fired residential furnaces and hard-coal 79 
combustion21-22 but not in wood smoke PM.23  Substituted B[j]As, such as 3-methyl- and 1,2-80 
dihydro-3-methyl-B[j]A, have been determined in coal tar pitch, cigarette smoke and air 81 
PM.24-27 To date, very few studies have analyzed the levels of B[j]A in air PM28 and to the 82 
authors’ knowledge no epidemiological studies have investigated the carcinogenicity of 83 
B[j]A. 84 
 85 
In the present study we have quantified the concentration of B[j]A in urban air PM collected 86 
in Stockholm, Sweden and Limeira, Brazil. Our analytical setup allowed for detection and 87 
5 
 
quantification of very low levels of B[j]A in air PM samples from the two city locations. We 88 
have also investigated the effects of B[j]A on cell viability, DNA damage and activation of 89 
DNA damage signaling in human-derived hepatocellular carcinoma (HepG2) cells to evaluate 90 
its potency relative to B[a]P. Taken together our results show that although levels of B[j]A 91 
are very low in the air PM samples, it is significantly more potent than B[a]P and  thus is 92 
likely to be an important contributor to the cancer risk of air PM. 93 
 94 
MATERIAL AND METHODS 95 
 96 
Chemicals and reagents 97 
 98 
Hexane, acetone and toluene (HPLC grade) were obtained from Rathburn Ltd. (Walkerburn 99 
Scotland) and dodecane (anhydrous, ≥99%) from Sigma-Aldrich (St. Louis, MO, USA). 100 
Synthesized B[j]A (purity determined to be at least 95% by NMR) was kindly provided by 101 
Dr. Avram Gold  and Dr. Zhenfa Zhang, University of North Carolina, Chapel Hill, NC, 102 
USA. B[a]P-D12 (98.7%) was supplied by Chiron AS (Trondheim, Norway) and 103 
benzo[b]fluoranthene (100%) and benzo[k]fluoranthene (98.3%) were obtained from Chem 104 
Service (West Chester, PA, USA). B[a]P (97.6%), benzo[e]pyrene (99.7%) and perylene 105 
(99.5%) were from Sigma-Aldrich (St. Louis, MO, USA). Benzo[a]fluoranthene was 106 
obtained from National Institute of Standards and Technology (Gaithersburg, MD, USA), and 107 
benzo[j]fluoranthene (100%) was from Larodan Fine Chemicals AB (Limhamn, Sweden). All 108 
cell culture reagents were supplied by Gibco (Life Technologies, Stockholm, Sweden). 109 
Antibodies used for Western blotting were phospho-Chk1 (Ser317), phospho-H2AX (Ser139) 110 
and phospho-p53 (Ser15)from Cell Signaling Technology (Beverly, MA, USA), and p53 111 
(DO-1), Cdk2 (M2) and secondary anti-mouse and anti-rabbit antibodies from Santa Cruz 112 
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(Santa Cruz, CA, USA). For immunocytochemistry, anti-phospho H2AX (Ser139, clone 113 
JBW301) was from EMD Millipore Corp. (Billerica, MA, USA) and secondary Alexa Fluor 114 
594 goat anti-mouse from Molecular Probes (Life Technologies, Stockholm, Sweden). 115 
 116 
Air sampling 117 
 118 
Two collection sites for air PM were used: Stockholm University, Stockholm, Sweden and 119 
the Faculty of Technology, UNICAMP, Limeira, Brazil. The Stockholm sampling has been 120 
described previously.10 Briefly, three air PM samples (STO1, STO2 and STO3) were 121 
collected on fluorocarbon coated glass fiber filters (Ø = 235 mm, Fiberfilm Filters, Pallflex, 122 
Pall Corporation, Putnam, CT, USA) at roof top level using an in-house pump device for 123 
three or seven days at an average flow rate of 70.6 m3/hr. The filters were desiccated for at 124 
least 24 h before and after the sampling. In Limeira, two air PM samples (LMR1 and LMR2) 125 
were collected on glass fiber filters (254 × 233 mm, 0.33 mm pore size, Energética Ind. Com. 126 
LTDA, Rio de Janeiro, RJ, Brazil) at the street level. The sampling was performed with a 127 
high-volume sampler (Energética Ind. Com. LTDA, Rio de Janeiro, RJ, Brazil) for 24 h at an 128 
average flow rate of 67.8 m3/hr. Until extraction filters from both Stockholm and Limeira 129 
were wrapped in aluminum and stored at -20 oC.  130 
 131 
Sample preparation and LC-GC/MS analysis 132 
 133 
A pressurized liquid extraction system (ASE 200 Accelerated Solvent Extraction System, 134 
Dionex Co., Sunnyvale, CA, USA) was used for the filter extraction. Samples were extracted 135 
with toluene for 5 consecutive cycles of 30 min. Then, 0.6 mL of the extract (corresponding 136 
to 56.1 m3, 214.6 m3, 144.5 m3, 34.5 m3 and 26.3 m3 for STO1, STO2, STO3, LMR1 and 137 
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LMR2, respectively) was spiked with 60 µL of 442 pg/µL B[a]P-D12 and applied to an SPE 138 
column (silica, 100 mg, IST Isolute, Biotage, Cardiff, UK). A PAH enriched fraction was 139 
obtained by elution with 2 mL of hexane. The final hexane eluate was evaporated until 100 140 
µL under a gentle nitrogen stream and transferred to a 300 µL micro vial for LC-GC/MS 141 
analysis. All sample preparations were performed in triplicate. The extraction and SPE clean-142 
up procedures29 and the LC-GC/MS method30 are described in detail elsewhere. Blank 143 
samples were prepared in the same manner using blank filters. 144 
 145 
Cell culture and exposure to PAHs 146 
 147 
Human-derived hepatocellular carcinoma cells (HepG2) were obtained from American Type 148 
Culture Collection (Rockville, MD, USA) at passage 78 and used within 20 passages for all 149 
experiments. The rationale for using this cell line in these studies is the capacity to 150 
metabolize PAHs31 and previously demonstrated response to low levels of PAHs.32-34 Cells 151 
were cultured in Minimal Essential Medium supplemented with 10% fetal bovine serum, 1 152 
mM sodium pyruvate, 0.1 mM non-essential amino acids, 100 units/ml penicillin and 0.1 153 
mg/ml streptomycin, and maintained at 37°C in 5% CO2. Cells were exposed to solvent 154 
control (0.1% DMSO), B[j]A or B[a]P for up to 48 h. 155 
 156 
MTT assay 157 
 158 
Cell viability was assessed using MTT assay as described previously.35 Briefly, HepG2 cells 159 
(0.3 x 105) were plated in 24-well plates (Corning Inc., Corning, NY, USA) and allowed to 160 
grow for 24 h. Cells were exposed to solvent control, B[j]A or B[a]P for 48 h in 1.5 ml 161 
medium and thereafter incubated with 0.5 mg/ml MTT reagent in 250 µl HBSS for 4 h. 162 
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Subsequently, formazan crystals were dissolved in 500 µl DMSO (15 min, shaking) and 163 
plates were spectrophotometrically analyzed at 570 nm with a reference wavelength at 690 164 
nm (Wallac Victor3 V 1420 multilabel counter, Perkin Elmer, Waltham, MA, USA). Results 165 
are presented as percent of solvent control and EC50 was established using non-linear 166 
regression in GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). 167 
 168 
Comet assay 169 
 170 
The alkaline comet assay was performed as described previously.36 In brief, HepG2 cells (0.3 171 
x 105) were plated in 24-well plates (Corning Inc., Corning, NY, USA) and grown for 24 h 172 
prior to exposure to solvent control, B[j]A or B[a]P in 1.5 ml for 48 h. Cells were trypsinized 173 
and mixed with 0.75% w/v low melting point agarose and smeared on slides pre-coated with 174 
0.3% agarose. Slides were incubated in cold lysis buffer (1% Triton X-100, 2.5 M NaCl, 10 175 
mM Tris, 0.1 M EDTA, pH 10) for 1 h on ice followed by incubation in cold alkaline 176 
solution (0.3 M NaOH, 1 mM EDTA, pH >13) for 40 min on ice. Electrophoresis was run in 177 
the alkaline solution at 29 V (1.15 V/cm) for 30 min and thereafter slides were neutralized in 178 
0.4 M Tris-HCl, pH 7.5, dried overnight and fixed in methanol for 5 min. After ethidium 179 
bromide staining, at least 100 cells were scored per treatment using a Leica DMLB 180 
fluorescent microscope and Comet Assay IV (Perceptive Instruments Ltd., Haverhill, UK). 181 
 182 
Immunocytochemistry 183 
 184 
HepG2 cells (0.2 x 104) were plated in 12-well plates containing 13 mm glass cover slips and 185 
grown for 24 h before exposure to solvent control, B[j]A or B[a]P in 2.0 ml for 48 h. Cells 186 
were washed and fixed in 4% paraformaldehyde for 20 min at room temperature and then 187 
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permeabilized with 0.2% Triton X-100 for 10 min followed by blocking in 2% bovine serum 188 
albumin in TBS-Tween 0.1% with 5% normal goat serum. Incubation with primary antibody 189 
was overnight at 4°C followed by washing and incubation with secondary antibody for 1 h in 190 
the dark. Cell nuclei were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) prior to 191 
mounting with Vectashield H-1000 mounting medium (Vector Labs, Burlingame, CA, USA). 192 
Images were captured using a 63x oil immersion objective on an LSM 510 Meta confocal 193 
laser scanning microscope (Zeiss, Göttingen, Germany). Cell foci were counted using 194 
CellProfiler cell image analysis software version 2.1.0 (MIT and Broad Institute, Cambridge, 195 
MA, USA).37  196 
 197 
For determining statistical effects in the immunocytochemistry experiments, we estimated the 198 
expected mean count in each exposure group with a linear regression model for each 199 
experiment separately. The experimental groups were introduced by means of indicator 200 
variables and count data analyzed marginally with respect to the experiment’s day. We used 201 
the sandwich robust estimator for the standard errors38 which is robust to misspecification of 202 
the modeling assumptions (e.g. homoscedasticity). The analyses were performed in Stata 203 
version 13 (StatCorp, Collage Station, TX, USA). 204 
 205 
Western Blotting 206 
 207 
Western blotting was performed as described previously32 with minor modifications. HepG2 208 
cells (4.0 x 105) were plated in 6-well plates (Corning Inc., Corning, NY, USA) and cultured 209 
for 72 h. Cells were exposed to solvent control, B[j]A or B[a]P for 48 h, washed with ice-210 
cold PBS and scraped into IPB-7 buffer containing protease inhibitors. Protein concentration 211 
was measured and samples subjected to standard SDS-PAGE. Subsequently, proteins were 212 
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transferred to PVDF membrane (Bio-Rad, Hercules, CA) and protein levels were detected 213 
using specific antibodies and visualized using enhanced chemiluminescence (Amersham GE 214 
Healthcare, Bio-Sciences AB, Uppsala, Sweden). Densitometric analysis was performed 215 
using ImageJ software version 1.48f (National Institute of Health, USA). 216 
 217 
Cancer risk assessment 218 
 219 
In order to estimate the excess lifetime cancer risk for inhalation exposure to PAHs in air PM, 220 
B[a]P equivalency concentrations (B[a]Peq) were determined using current RPF scales (Table 221 
S1).39 The contribution to the cancer risk from B[j]A was estimated using published RPFs15-222 
16,40-41 and potency factors based on H2AX and Chk1 activation. The cancer risk was 223 
determined by multiplying PAH concentration with a unit risk (per 100 000 people) for B[a]P 224 
set by WHO4 to 8.7×10-5 ng/m3 (based on epidemiological study of coke oven workers) using 225 
the equation below.  226 
 227 
Cancer risk = ∑([PAH] × RPFPAH) × unit risk 228 
 229 
Statistics 230 
 231 
All data presented are means ± standard error (SE). With the exception of the 232 
immunocytochemistry analysis (described above), One-Way ANOVA with Bonferroni’s t-233 
test correction was used to determine statistical significance (p<0.05). 234 
 235 
RESULTS 236 
 237 
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Detection limit and linearity 238 
 239 
A series of six B[j]A standard solutions were injected on the LC-GC/MS system in triplicate 240 
and a calibration curve of the area ratio (B[j]A/B[a]P-D12) against the amount of B[j]A was 241 
plotted in the range of 2−493 pg B[j]A spiked with 10 µL of 442 pg/µL B[a]P-D12. A GC/MS 242 
chromatogram of a calibration standard is shown in Fig. S1. The coefficient of determination 243 
(R2) was 0.9975 and the limit of detection (at a signal to noise ratio (S/N) of 4.2) and limit of 244 
quantification (at a S/N of 14.9) were determined to be 2.5 and 12 pg, respectively.  245 
 246 
Determination of B[j]A in air PM 247 
 248 
Representative GC/MS chromatograms of air PM samples from Stockholm and Limeira are 249 
shown in Fig. 1A and 1B, respectively. The B[j]A peak was well-separated from the other 250 
seven molecular weight 252 Da isomers detected, whilst partially co-eluting with an 251 
unknown peak displaying a characteristic PAH mass spectrum (mother ion m/z 268). 252 
Together with mass spectra, the peak identification was confirmed by comparing the 253 
retention time of B[j]A from the original and spiked samples in the GC/MS chromatograms 254 
as shown in Fig. 1C and 1D. No detectable amount of B[j]A was found in blank samples 255 
generated by extracting the different filter types used for sampling air PM in Stockholm and 256 
Limeira (Fig. S2). Sample identities and collection details including levels of B[a]P and 257 
B[j]A in the air PM from Stockholm and Limeira are summarized in Table 1. Determined 258 
B[j]A concentrations were between 11 to 30 times less than those of B[a]P. The 259 
concentrations of all PAHs determined in the air PM samples are shown in Table S2. The 260 
levels of PAHs in STO1 and LMR2 have previously been published.42  261 
 262 
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B[j]A exerts stronger effects on cell viability than B[a]P consistent with increased DNA 263 
damage 264 
 265 
In vitro studies have shown that B[j]A is a genotoxic agent and a more potent inducer of 266 
apoptosis than B[a]P.17,43 In agreement, we found that B[j]A was more toxic to the cells than 267 
B[a]P in the MTT assay (Fig. 2A). The estimated EC50 value for cell viability was 0.39±0.20 268 
and 1.45±0.09 μM for B[j]A and B[a]P, respectively. A statistically significant decrease in 269 
cell viability compared to control levels was observed after exposure to 2.0 µM B[a]P or 0.3 270 
μM B[j]A (p<0.001). There was also a significant difference between cells exposed to 271 
equimolar concentrations of B[j]A and B[a]P at 0.3 and 1.0 μM (p<0.001). 272 
 273 
Increased potency between different PAHs has previously been shown to be intrinsically 274 
linked to their ability to form DNA damage and the persistence of this damage/resistance to 275 
repair.44-46 We therefore hypothesized that in a comparable manner, the increased toxicity of 276 
B[j]A over B[a]P correlates with differences in DNA damage levels. A single exposure time 277 
of 48 h was chosen for these analyses as we have previously used this time point to study the 278 
effects of individual and mixtures of PAHs on DNA damage.32-33 Significantly increased 279 
levels of DNA damage were observed in the Comet assay after exposure to 1.0 µM B[a]P 280 
(p<0.001) or 0.3 µM B[j]A (p<0.001) when compared to control levels (Fig. 2B). No 281 
significant changes in DNA damage levels were observed after exposure to 0.3 μM B[a]P 282 
(Fig. 2B) or 0.1 μM B[j]A (data not shown). Comparing equimolar concentrations showed 283 
that B[j]A induced significantly more DNA damage than B[a]P (p<0.001). These results were 284 
further confirmed by immunostaining for formation of phosphorylated H2AX (Ser139) foci 285 
(γH2AX). Visual comparison between treatments showed more foci formation in response to 286 
B[j]A>B[a]P>DMSO control (Fig. 2C). Both the B[a]P group and the B[j]A group had 287 
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higher foci rate compared to control group, 5.7 and 17.2 times more, respectively (p<0.001) 288 
(Fig. 2D). The number of foci in B[j]A exposed cells were also significantly higher from that 289 
in the equimolar B[a]P group (p<0.001). Taken together these data show that B[j]A is 290 
significantly more potent than B[a]P in reducing cell viability and that this most likely results 291 
from increased damage to DNA. 292 
 293 
B[j]A induces a stronger activation of DNA damage signaling than B[a]P 294 
 295 
In agreement with the Comet assay and γH2AX foci results, our data revealed B[j]A to be a 296 
more potent inducer of DNA damage signaling than B[a]P. At 1 μM, B[j]A induced 297 
phosphorylation of Chk1 Ser317 (pChk1), γH2AX and p53 Ser15 (pp53) to a higher extent 298 
than B[a]P (Fig. 3A). Total p53 level was also more elevated in response to B[j]A compared 299 
to B[a]P as well as the protein level of the cell cycle regulator p21. To further study the 300 
difference in potencies between B[j]A and B[a]P we applied a dose response analysis for the 301 
induction of pChk1, pp53 and γH2AX. As can be seen, B[j]A induced phosphorylation of all 302 
proteins at lower concentration compared to B[a]P (Fig. 3B and 3C). To allow for a 303 
quantitative comparison of potency, densitometric analysis of pChk1 and γH2AX levels (Fig. 304 
3C) was used to estimate the concentrations of B[j]A and B[a]P required to induce a 305 
particular fold induction of the proteins (Table S3). Due to no visible bands of pp53 in 306 
control and at lower concentrations of B[j]A and B[a]P proper densitometry analysis and 307 
comparison of potencies could not be accurately performed. For comparison, we included 308 
previous data from DBC exposures.32 DBC induces pChk1 at lower concentrations compared 309 
to B[j]A whereas γH2AX was induced similarly by DBC and B[j]A (Fig. 3C). The results 310 
showed that levels of pChk1 increased at lower levels for B[j]A compared to γH2AX, in 311 
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agreement with our previous data.32 On average B[j]A was 12.5- and 33.3-fold more potent 312 
inducer of pChk1 and γH2AX levels, respectively, compared to B[a]P. 313 
 314 
Contribution of B[j]A to air PM cancer risk 315 
 316 
If only the B[a]P concentration in air PM was considered the estimated excess lifetime cancer 317 
cases per 100 000 people was 0.15-2.5 (ex. STO1: 0.289 ng B[a]P/m3 × 8.7×10-5 = 2.5×10-5) 318 
and 4.9-7.8 for Stockholm and Limeira, respectively (Table 2). Next we calculated the excess 319 
lifetime cancer cases based on all the determined PAHs in the air PM samples (except B[j]A) 320 
with an assigned RPF value. Compared to the excess lifetime cancer cases based on levels of 321 
B[a]P alone, the cases increased to 0.77-11.3 and 16.2-22.7 per 100 000 people for 322 
Stockholm and Limeira, respectively (Table 2). The additional contribution to the cancer risk 323 
by including B[j]A in the B[a]Peq levels was estimated using two different published RPFs 324 
for B[j]A of 10 and 6015-16,40-41 and our potency factor of 30 based on H2AX activation 325 
(Table 2). The published RPF of 10 was similar to our potency factor based on activation of 326 
Chk1. The results showed that inclusion of B[j]A increased the estimated cancer risk of the 327 
air PM. Depending on which potency factor that was applied, inclusion of B[j]A resulted in 328 
an up to doubling of expected excess lifetime cancer cases (Table 2). This provides 329 
convincing evidence that B[j]A contributes  to the carcinogenic potency of urban air PM and 330 
warrants further investigation. 331 
 332 
DISCUSSION 333 
 334 
Concentrations of B[j]A in urban air PM 335 
 336 
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The present study determined the atmospheric B[j]A concentration in air PM collected at two 337 
different locations, Stockholm, Sweden and Limeira, Brazil. The air PM from Limeira 338 
contained higher levels of PAHs compared to the samples from Stockholm. Besides the 339 
probable difference in PAH levels due to emission profiles in the respective areas, the 340 
samples from Limeira were collected at street level while in Stockholm sampling was 341 
performed on a roof top. PAHs at the Limeira site can be mostly attributed to heavy traffic 342 
and biomass burning whereas traffic is a main source at the Stockholm site.47 The PAH levels 343 
in Stockholm air PM displayed large seasonal changes during the different sampling periods: 344 
the B[a]P concentration was 17.3 pg/m3 in September and increased to 49.5 and 289 pg/m3 in 345 
December and January, respectively. The B[j]A concentration followed the same trend: 1.57, 346 
3.14 and 12.7 pg/m3, as well as the other measured PAHs and this is in line with recently 347 
reported PAH levels from the Stockholm atmosphere showing a high annual variability with 348 
higher concentrations during the colder parts of the year.48 Higher PAH levels during the 349 
winter season in cities around the world has been attributed to meteorological conditions such 350 
as inversion and lower mixing layer, less efficient atmospheric reactions and increase in 351 
emissions from domestic heating.49 The two air PM samples from Limeira were both 352 
collected in July and had higher concentration of B[a]P, B[j]A  and of most of the other 353 
investigated PAHs with a few exceptions compared to the Stockholm samples. A previous 354 
study of air PM PAHs in Saitama City, Japan, reported measurements of 37 PAHs including 355 
B[a]P, B[j]A and DBC and to our knowledge it is the only other study reporting measurement 356 
of B[j]A in urban air.28 The concentrations of these PAHs in total air PM was 270, 130 and 357 
70 pg/m3 for B[a]P, B[j]A and DBC, respectively. The levels of B[a]P in Saitama (sampling 358 
period November-December 2013) was similar to STO1, exceeded STO2 and STO3 and was 359 
less than LMR1 and LMR2. For B[j]A and DBC the levels were much higher in Saitama 360 
compared to all our investigated samples. Further studies to investigate the generation and 361 
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deposition of PAHs in the different locales might explain the observed differences in B[j]A 362 
and DBC levels. 363 
 364 
Stronger activation of DNA damage and DNA damage signaling after exposure to B[j]A 365 
 366 
In HepG2 cells, B[j]A was significantly more toxic than B[a]P. This is in agreement with a 367 
previous study performed in mouse Hepa1c1c7 hepatoma cells showing that B[j]A is a 368 
stronger inducer of apoptosis compared to B[a]P.43 As mentioned before, previous studies 369 
have correlated increased potency of PAHs with the ability to form DNA adducts and 370 
avoidance of repair. The Comet assay revealed that B[j]A was significantly more genotoxic 371 
than B[a]P at equimolar concentrations and this is in line with earlier studies showing that 372 
B[j]A induces more DNA adducts in rat and human liver microsomes compared to B[a]P.19-20 373 
Comparing the cytotoxic and genotoxic potencies of the two compounds showed that the 374 
cytotoxic doses of B[j]A were also genotoxic, this was not true for 1 µM B[a]P which was 375 
genotoxic but not cytotoxic. The increase in genotoxicity was further confirmed by 376 
immunostaining for phosphorylated H2AX (γH2AX). H2AX is rapidly phosphorylated (at 377 
Ser139) at sites of DNA damage, both in response to strand breaks and stable DNA adducts, 378 
forming γH2AX foci  that can be detected by immunocytochemistry.50-51 Furthermore, 379 
phosphorylation of H2AX in the early stages of damage detection is attributed to the 380 
propagation of DNA damage signaling and hence we also analyzed levels of γH2AX by 381 
Western blotting alongside other major DNA damage signaling proteins including Chk1, p21 382 
and p53. We found B[j]A to be a stronger inducer of all investigated signaling proteins.  383 
 384 
From the dose response curves of pChk1 and γH2AX we calculated the PAH concentrations 385 
needed to induce a fold change in activated protein levels as described earlier.32 These 386 
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proteins have previously been shown to be sensitive markers for studying genotoxic potencies 387 
of both individual and mixtures of PAHs.32-33,52 We calculated the difference in potency of 388 
B[j]A compared to B[a]P to be 12.5- and 33.3-fold for pChk1 and γH2AX, respectively. 389 
Previous studies have reported RPFs of 10 and 60 for B[j]A. The RPF of 10 is based on 390 
Ames test where an approximate 10-fold lower concentration of B[j]A compared to B[a]P 391 
induce optimal activity in S9 dependent test.40-41 Similarly in SENCAR mice treated topically 392 
with B[j]A tumor initiation was 12 times higher compared to B[a]P.16 The RPF of 60 is based 393 
on B[j]A inducing 16-60 times more lung tumors in A/J mice subjected to a single 394 
intraperitoneal injection relative to B[a]P.15 These tumor data are in the same range as the 395 
fold induction data generated in the present study from the phosphorylation of Chk1 and 396 
H2AX. It has previously been shown for DBC that fold induction data generated from DNA 397 
damage signaling in vitro is in agreement with animal experiments regarding carcinogenic 398 
potency suggesting that activation of the DNA damage response could serve as a marker for 399 
in vitro testing of PAH potency.5,32 The higher sensitivity of pChk1 and γH2AX compared to 400 
Comet assay data and the close agreement with published RPFs motivated us to include our 401 
potency factors based on activation of DNA damage signaling in the cancer risk estimation as 402 
further discussed below. 403 
 404 
Risk assessment of air PM and contribution of B[j]A to lifetime cancer risk 405 
 406 
PAHs have been suggested to be the group of airborne contaminants that contribute most to 407 
human health risk. In urban sites 83-94% of the health risk was related to particle associated 408 
compounds and of these PAHs was responsible for 99% of the risk.53 An investigation of 409 
excess lifetime cancer risk in different age categories in Cordoba, Argentina, showed that 410 
already in the age category 1-6 years one child out of one million would get cancer as a result 411 
18 
 
of airborne PAH exposure.54 In the present study the excess lifetime cancer cases was 412 
estimated based on B[a]Peq levels and the WHO unit risk value 8.7×10-5 ng B[a]P /m3.4 We 413 
showed that the air samples from Limeira were more polluted by PAHs than the Stockholm 414 
samples which was also reflected in a higher number of expected excess lifetime cancer 415 
cases, 17.9-38.4 and 0.91-18.0 cases per 100 000 people, respectively. Furthermore, our 416 
results showed that B[j]A greatly contributes to the cancer risk of air PM despite the low 417 
concentrations that we detected. Although B[j]A levels in air were low, including B[j]A in 418 
the estimation of excess lifetime cancer risk increased the risk up to 2-fold depending on 419 
which potency factor for B[j]A was applied. The importance of including highly potent 420 
PAHs, even though found in low levels, in the cancer risk assessment of air PM is further 421 
confirmed by recent studies. Layshock et al., showed that excluding the dibenzopyrenes 422 
when assessing air quality most likely results in a substantial underestimation of the health 423 
risk.12 A calculated increase in lifetime risk of developing lung cancer for residents in 424 
Beijing, China, due to PAHs in air PM, may be 1 out of 10 000 to over 6 out of 100 and half 425 
of that risk was estimated to be related to levels of the dibenzopyrenes.12 The importance of 426 
including high-molecular weight PAHs, such as the dibenzopyrenes, has also been 427 
emphasized in other studies showing a significant contribution to the estimated excess 428 
lifetime cancer risk of air PM.11,13,55 It should be noted that B[j]A was not included in any of 429 
the above mentioned studies which probably further resulted in an underestimation of the 430 
cancer risk. 431 
 432 
In this study we focused on excess lifetime cancer risk from exposure to inhaled air PM 433 
PAHs. We are aware of the limitations in the estimation such as the shortcomings of using 434 
RPFs which in the case of B[j]A are based on data from Ames test and in vivo dermal and 435 
intraperitoneal exposure when assessing the cancer risk for inhaled air PM. Further to give a 436 
19 
 
more comprehensive view of excess lifetime cancer risk, the PAH levels should be monitored 437 
over the whole year to include the seasonal variations in PAH constituents. It is very apparent 438 
in the three Stockholm samples that the time of sampling greatly affects the PAH levels and 439 
in turn the cancer risk estimate. 440 
 441 
SUPPORTING INFORMATION 442 
 443 
Supporting information available: Tables S1-S3 (air PM B[a]Peq levels, chemical analysis of 444 
air PM samples and fold induction of DNA damage signaling) and Figures S1-S2 (GC/MS 445 
chromatograms). This material is available free of charge via the internet at 446 
http://pubs.acs.org. 447 
 448 
ACKNOWLEDGEMENTS 449 
 450 
The authors are grateful to Dr. Avram Gold and Dr. Zhenfa Zhang from the University of 451 
North Carolina at Chapel Hill, USA for kindly providing the B[j]A standard for the present 452 
study. This work was supported by Stockholm University, Karolinska Institutet and the 453 
Swedish Research Council Formas (R&D project No. 2012-478). 454 
 455 
REFERENCES 456 
 457 
1. Loomis, D.; Grosse, Y.; Lauby-Secretan, B.; El Ghissassi, F.; Bouvard, V.; 458 
Benbrahim-Tallaa, L.; Guha, N.; Baan, R.; Mattock, H.; Straif, K., The carcinogenicity of 459 
outdoor air pollution. Lancet Oncol 2013, 14 (13), 1262-3. 460 
20 
 
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Some 461 
Non-Heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures. IARC 462 
Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for 463 
Research on Cancer, Ed. IARC Press: Lyon, France., 2010; Vol. 92. 464 
3. Boström, C. E.; Gerde, P.; Hanberg, A.; Jernström, B.; Johansson, C.; Kyrklund, T.; 465 
Rannug, A.; Törnqvist, M.; Victorin, K.; Westerholm, R., Cancer risk assessment, indicators, 466 
and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health 467 
Perspect 2002, 110 (Suppl 3), 451-88. 468 
4. World Health Organisation (WHO), Air Quality Guidelines for Europe, Second 469 
Edition. WHO Regional Publications, European Series, No. 91. World Health Organization 470 
(WHO) Regional Office for Europe, Ed. WHO: Copenhagen, Denmark., 2000. 471 
5. Jarvis, I. W. H.; Dreij, K.; Mattsson, A.; Jernström, B.; Stenius, U., Interactions 472 
between polycyclic aromatic hydrocarbons in complex mixtures and implications for cancer 473 
risk assessment. Toxicology 2014, 321, 27-39. 474 
6. Luch, A., On the impact of the molecule structure in chemical carcinogenesis. In 475 
Molecular, Clinical and Environmental Toxicology, Luch, A., Ed. Birkhäuser Basel: 2009; 476 
Vol. 99, pp 151-179. 477 
7. Siddens, L. K.; Larkin, A.; Krueger, S. K.; Bradfield, C. A.; Waters, K. M.; Tilton, S. 478 
C.; Pereira, C. B.; Lohr, C. V.; Arlt, V. M.; Phillips, D. H., et al., Polycyclic aromatic 479 
hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene 480 
and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol 2012, 264 481 
(3), 377-86. 482 
8. Brown, A. S.; Brown, R. J.; Coleman, P. J.; Conolly, C.; Sweetman, A. J.; Jones, K. 483 
C.; Butterfield, D. M.; Sarantaridis, D.; Donovan, B. J.; Roberts, I., Twenty years of 484 
21 
 
measurement of polycyclic aromatic hydrocarbons (PAHs) in UK ambient air by nationwide 485 
air quality networks. Environ Sci Process Impacts 2013, 15 (6), 1199-215. 486 
9. Okona-Mensah, K. B.; Battershill, J.; Boobis, A.; Fielder, R., An approach to 487 
investigating the importance of high potency polycyclic aromatic hydrocarbons (PAHs) in the 488 
induction of lung cancer by air pollution. Food Chem Toxicol 2005, 43 (7), 1103-16. 489 
10. Bergvall, C.; Westerholm, R., Identification and determination of highly carcinogenic 490 
dibenzopyrene isomers in air particulate samples from a street canyon, a rooftop, and a 491 
subway station in Stockholm. Environ Sci Technol 2007, 41 (3), 731-7. 492 
11. Jia, Y.; Stone, D.; Wang, W.; Schrlau, J.; Tao, S.; Simonich, S. L., Estimated 493 
reduction in cancer risk due to PAH exposures if source control measures during the 2008 494 
Beijing Olympics were sustained. Environ Health Perspect 2011, 119 (6), 815-20. 495 
12. Layshock, J.; Simonich, S. M.; Anderson, K. A., Effect of dibenzopyrene 496 
measurement on assessing air quality in Beijing air and possible implications for human 497 
health. J Environ Monit 2010, 12 (12), 2290-8. 498 
13. Menichini, E.; Merli, F., Dibenzopyrenes, other PAHs with molecular weight 302, 499 
and selected carcinogenic PAHs seldom determined: identification and one-year 500 
quantification in urban air. Intern J Environ Anal Chem 2012, 92 (14), 1609-1625. 501 
14. Slezakova, K.; Pires, J. C.; Castro, D.; Alvim-Ferraz, M. C.; Delerue-Matos, C.; 502 
Morais, S.; Pereira, M. C., PAH air pollution at a Portuguese urban area: carcinogenic risks 503 
and sources identification. Environ Sci Pollut Res Int 2013, 20 (6), 3932-45. 504 
15. Mass, M. J.; Jeffers, A. J.; Ross, J. A.; Nelson, G.; Galati, A. J.; Stoner, G. D.; 505 
Nesnow, S., Ki-ras oncogene mutations in tumors and DNA adducts formed by 506 
benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol Carcinog 1993, 507 
8 (3), 186-92. 508 
22 
 
16. Nesnow, S.; Gold, A.; Sangaiah, R.; Slaga, T. J., Mouse skin tumor-initiating activity 509 
of benz[j]aceanthrylene in SENCAR mice. Cancer Lett 1993, 73 (2-3), 73-6. 510 
17. Holme, J. A.; Bjorge, C.; Soderlund, E. J.; Brunborg, G.; Becher, R.; Lag, M.; 511 
Schwarze, P. E.; Ross, J.; Nelson, G.; Nesnow, S., Genotoxic effects of cyclopenta-fused 512 
polycyclic aromatic hydrocarbons in isolated rat hepatocytes and rabbit lung cells. 513 
Carcinogenesis 1993, 14 (6), 1125-31. 514 
18. Nesnow, S.; Lasley, J.; Curti, S.; Ross, J.; Nelson, G.; Sangaiah, R.; Gold, A., 515 
Morphological transformation and DNA adduct formation by benz[j]aceanthrylene and its 516 
metabolites in C3H10T1/2CL8 cells: evidence for both cyclopenta-ring and bay-region 517 
metabolic activation pathways. Cancer Res 1991, 51 (22), 6163-9. 518 
19. Johnsen, N. M.; Brunborg, G.; Haug, K.; Scholz, T.; Holme, J. A., Metabolism and 519 
activation of cyclopenta polycyclic aromatic hydrocarbons in isolated human lymphocytes, 520 
HL-60 cells and exposed rats. Chem Biol Interact 1998, 114 (1-2), 77-95. 521 
20. Johnsen, N. M.; Nyholm, S. H.; Haug, K.; Scholz, T.; Holme, J. A., Metabolism and 522 
activation of cyclopenta polycyclic aromatic hydrocarbons in liver tissue from rats and 523 
humans. Chem Biol Interact 1998, 113 (3), 217-37. 524 
21. Grimmer, G.; Jacob, J.; Dettbarn, G.; Naujack, K. W., Determination of polycyclic 525 
aromatic hydrocarbons, azaarenes, and thiaarenes emitted from coal-fired residential furnaces 526 
by gas chromatography/mass spectrometry. Fresenius' Zeitschrift für analytische Chemie 527 
1985, 322 (6), 595-602. 528 
22. Schmidt, W.; Grimmer, G.; Jacob, J.; Dettbarn, G., Polycyclic aromatic hydrocarbons 529 
and thiaarenes in the emission from hard-coal combustion. Toxicol Environ Chem 1986, 13 530 
(1-2), 1-16. 531 
23 
 
23. Kamens, R. M.; Fulcher, J. N.; Ball, L. M.; Gold, A., Analysis of cyclopentafused 532 
isomers of benz(a)anthracene in wood smoke. Biomed Environ Mass Spectrom 1987, 14 (8), 533 
369-74. 534 
24. Gao, H.; Zhou, L.; Ma, M. Q.; Chen, X. G.; Hu, Z. D., Composition and source of 535 
unknown organic pollutants in atmospheric particulates of the Xigu District, Lanzhou, 536 
People's Republic of China. Bull Environ Contam Toxicol 2004, 72 (5), 923-30. 537 
25. Li, Z.; Wu, Y.; Zhao, Y.; Wang, L.; Zhu, H.; Qin, L.; Feng, F.; Wang, W., Analysis of 538 
coal tar pitch and smoke extract components and their cytotoxicity on human bronchial 539 
epithelial cells. J Hazard Mater 2011, 186 (2-3), 1277-82. 540 
26. Rodgman, A.; Smith, C. J.; Perfetti, T. A., The composition of cigarette smoke: a 541 
retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 2000, 19 (10), 542 
573-95. 543 
27. Suzuki, S.; Kaneko, T.; Tsuchiya, M., Characterization of C12 to C45 polycyclic 544 
aromatic hydrocarbons and fused-ring heterocyclic compounds in coal tar pitch and airborne 545 
total suspended particle. J Environ Chem 1996, 6 (4), 511-520. 546 
28. Wang, Q.; Kobayashi, K.; Zhou, M.; Lu, S.; Dong, S.; Nakajima, D.; Sekigushi, K.; 547 
Terasaki, M., Study on the size-segregated distribution of 37 species of polycyclic aromatic 548 
hydrocarbons in urban atmospheric fine particles of Japan. In Air Pollution XXII, Longhurst, 549 
J.; Brebbia, C., Eds. WIT Press: 2014; pp 131-143. 550 
29. Bergvall, C.; Westerholm, R., Determination of 252-302 Da and tentative 551 
identification of 316-376 Da polycyclic aromatic hydrocarbons in Standard Reference 552 
Materials 1649a Urban Dust and 1650b and 2975 Diesel Particulate Matter by accelerated 553 
solvent extraction-HPLC-GC-MS. Anal Bioanal Chem 2008, 391 (6), 2235-48. 554 
30. Sadiktsis, I.; Koegler, J. H.; Benham, T.; Bergvall, C.; Westerholm, R., Particulate 555 
associated polycyclic aromatic hydrocarbon exhaust emissions from a portable power 556 
24 
 
generator fueled with three different fuels – A comparison between petroleum diesel and two 557 
biodiesels. Fuel 2014, 115 (0), 573-580. 558 
31. Knasmuller, S.; Parzefall, W.; Sanyal, R.; Ecker, S.; Schwab, C.; Uhl, M.; Mersch-559 
Sundermann, V.; Williamson, G.; Hietsch, G.; Langer, T., et al., Use of metabolically 560 
competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res 561 
1998, 402 (1-2), 185-202. 562 
32. Jarvis, I. W. H.; Bergvall, C.; Bottai, M.; Westerholm, R.; Stenius, U.; Dreij, K., 563 
Persistent activation of DNA damage signaling in response to complex mixtures of PAHs in 564 
air particulate matter. Toxicol Appl Pharmacol 2013, 266 (3), 408-418. 565 
33. Niziolek-Kierecka, M.; Dreij, K.; Lundstedt, S.; Stenius, U., H2AX, pChk1, and 566 
Wip1 as potential markers of persistent DNA damage derived from dibenzo[a,l]pyrene and 567 
PAH-containing extracts from contaminated Soils. Chem Res Toxicol 2012, 25 (4), 862-72. 568 
34. Tarantini, A.; Maitre, A.; Lefebvre, E.; Marques, M.; Marie, C.; Ravanat, J. L.; 569 
Douki, T., Relative contribution of DNA strand breaks and DNA adducts to the genotoxicity 570 
of benzo[a]pyrene as a pure compound and in complex mixtures. Mutat Res 2009, 671 (1-2), 571 
67-75. 572 
35. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application 573 
to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65 (1-2), 55-63. 574 
36. Karlsson, H. L.; Nilsson, L.; Moller, L., Subway particles are more genotoxic than 575 
street particles and induce oxidative stress in cultured human lung cells. Chem Res Toxicol 576 
2005, 18 (1), 19-23. 577 
37. Carpenter, A. E.; Jones, T. R.; Lamprecht, M. R.; Clarke, C.; Kang, I. H.; Friman, O.; 578 
Guertin, D. A.; Chang, J. H.; Lindquist, R. A.; Moffat, J., et al., CellProfiler: image analysis 579 
software for identifying and quantifying cell phenotypes. Genome Biol 2006, 7 (10), R100. 580 
25 
 
38. Huber, P. J., The behavior of maximum likelihood estimates under nonstandard 581 
conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and 582 
Probability, Volume 1: Statistics, 221-233, University of California Press, Berkeley, CA, USA 583 
1967. 584 
39. Minnesota Department of Health., Guidance for evaluating the cancer potency of 585 
polycyclic aromatic hydrocarbon (PAH) mixtures in environmental samples. 2014 October 586 
31. 587 
40. Nesnow, S.; Leavitt, S.; Easterling, R.; Watts, R.; Toney, S. H.; Claxton, L.; 588 
Sangaiah, R.; Toney, G. E.; Wiley, J.; Fraher, P., et al., Mutagenicity of cyclopenta-fused 589 
isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat 590 
liver microsomal metabolites. Cancer Res 1984, 44 (11), 4993-5003. 591 
41. Sangaiah, R.; Gold, A.; Toney, G. E.; Toney, S. H.; Claxton, L.; Easterling, R.; 592 
Nesnow, S., Benz[j]aceanthrylene: a novel polycyclic aromatic hydrocarbon with bacterial 593 
mutagenic activity. Mutat Res 1983, 119 (3), 259-66. 594 
42. Umbuzeiro, G. A.; Kummrow, F.; Morales, D. A.; Alves, D. K.; Lim, H.; Jarvis, I. W. 595 
H.; Bergvall, C.; Westerholm, R.; Stenius, U.; Dreij, K., Sensitivity of salmonella YG5161 596 
for detecting PAH-associated mutagenicity in air particulate matter. Environ Mol Mutagen 597 
2014, 55 (6), 510-7. 598 
43. Solhaug, A.; Refsnes, M.; Lag, M.; Schwarze, P. E.; Husoy, T.; Holme, J. A., 599 
Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in 600 
Hepa1c1c7 cells. Carcinogenesis 2004, 25 (5), 809-19. 601 
44. Buterin, T.; Hess, M. T.; Luneva, N.; Geacintov, N. E.; Amin, S.; Kroth, H.; Seidel, 602 
A.; Naegeli, H., Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in 603 
ras codon 61 mutational hot spots. Cancer Res 2000, 60 (7), 1849-56. 604 
26 
 
45. Dreij, K.; Seidel, A.; Jernström, B., Differential removal of DNA adducts derived 605 
from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells. Chem Res 606 
Toxicol 2005, 18 (4), 655-64. 607 
46. Geacintov, N. E.; Broyde, S.; Buterin, T.; Naegeli, H.; Wu, M.; Yan, S.; Patel, D. J., 608 
Thermodynamic and structural factors in the removal of bulky DNA adducts by the 609 
nucleotide excision repair machinery. Biopolymers 2002, 65 (3), 202-10. 610 
47. Jarvis, I. W. H.; Bergvall, C.; Morales, D. A.; Kummrow, F.; Umbuzeiro, G. A.; 611 
Westerholm, R.; Stenius, U.; Dreij, K., Nanomolar levels of PAHs in extracts from urban air 612 
induce MAPK signaling in HepG2cells. Toxicol Lett 2014, 229 (1), 25-32. 613 
48. Westerholm, R.; Bergvall, C.; Sadiktsis, I.; Johansson, C.; Stenius, U., Mätning av 614 
starkt carcinogena dibensopyrener i jämförelse med humancarcinogenen bens(a)pyren 615 
[B(a)P] i Stockholmsluft från vägtrafik. Report (in Swedish) to the Stockholm county council. 616 
Stockholm (2012), p. 1 2012. 617 
49. Ravindra, K.; Sokhi, R.; Van Grieken, R., Atmospheric polycyclic aromatic 618 
hydrocarbons: Source attribution, emission factors and regulation. Atmospheric Environment 619 
2008, 42 (13), 2895-2921. 620 
50. Mattsson, A.; Jernström, B.; Cotgreave, I. A.; Bajak, E., H2AX phosphorylation in 621 
A549 cells induced by the bulky and stable DNA adducts of benzo[a]pyrene and 622 
dibenzo[a,l]pyrene diol epoxides. Chem Biol Interact 2009, 177 (1), 40-7. 623 
51. Rogakou, E. P.; Boon, C.; Redon, C.; Bonner, W. M., Megabase chromatin domains 624 
involved in DNA double-strand breaks in vivo. J Cell Biol 1999, 146 (5), 905-16. 625 
52. Audebert, M.; Zeman, F.; Beaudoin, R.; Pery, A.; Cravedi, J. P., Comparative potency 626 
approach based on H2AX assay for estimating the genotoxicity of polycyclic aromatic 627 
hydrocarbons. Toxicol Appl Pharmacol 2012, 260 (1), 58-64. 628 
27 
 
53. Bartos, T.; Cupr, P.; Klanova, J.; Holoubek, I., Which compounds contribute most to 629 
elevated airborne exposure and corresponding health risks in the Western Balkans? Environ 630 
Int 2009, 35 (7), 1066-71. 631 
54. Amarillo, A. C.; Tavera Busso, I.; Carreras, H., Exposure to polycyclic aromatic 632 
hydrocarbons in urban environments: Health risk assessment by age groups. Environ Pollut 633 
2014, 195C, 157-162. 634 
55. Wang, J.; Chen, S.; Tian, M.; Zheng, X.; Gonzales, L.; Ohura, T.; Mai, B.; Simonich, 635 
S. L., Inhalation cancer risk associated with exposure to complex polycyclic aromatic 636 
hydrocarbon mixtures in an electronic waste and urban area in South China. Environ Sci 637 
Technol 2012, 46 (17), 9745-52. 638 
 639 
  640 
28 
 
 641 
 642 
 643 
 644 
 645 
 646 
 647 
 648 
 649 
 650 
 651 
 652 
 653 
 654 
 655 
 656 
 657 
 658 
Fig. 1. Detection of B[j]A in air PM samples. GC/MS chromatograms obtained in SIM mode 659 
of air PM samples from Stockholm (A), Limeira (B), Stockholm spiked with B[j]A (C) and 660 
Limeira spiked with B[j]A (D). 1: benzo[b]fluoranthene, 2: benzo[k]fluoranthene, 3: 661 
benzo[j]fluoranthene, 4: benzo[a]fluoranthene, 5: unknown, 6: benz[j]aceanthrylene, 7: 662 
benzo[e]pyrene, 8: benzo[a]pyrene-D12, 9: benzo[a]pyrene, 10: perylene.   663 
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 677 
Fig. 2. B[j]A reduce cell viability and induce DNA damge stronger than B[a]P. HepG2 cells 678 
were exposed to B[j]A, B[a]P or control solvent (DMSO) for 48 h. MTT assay (A) of cells 679 
exposed to 0.001-1 μM B[j]A or 0.01-4 μM B[a]P where cell viability is presented as percent 680 
of DMSO treated cells. Comet assay (B) was performed on cells exposed to 0.3 and 1 μM 681 
B[j]A or B[a]P, or DMSO and 100 cells were scored (n=2). Sigmoidal dose response curve 682 
fit (n=6) was applied in A. One-way ANOVAs with Bonferroni’s post test was applied in A 683 
and B, * p<0.05 compared DMSO. Immunostaining (C) of γH2AX (red) and DAPI (blue) in 684 
cells exposed to 0.3 μM B[a]P or B[j]A, or DMSO. Scatter plot (D) of counted cells and foci 685 
from immunostaining with statistical significance obtained using a linear regression model.686 
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Fig. 3. Stronger activation of DNA damage signaling proteins in cells exposed to B[j]A 702 
compared to B[a]P. HepG2 cells were exposed to PAHs for 48 h and protein levels were 703 
measured with Western blot. In (A) the effect of equimolar concentration of B[j]A and B[a]P 704 
(1 μM) on pChk1, γH2AX, p53, pp53 and p21. Cdk2 was used as loading control. In (B) dose 705 
response of 0.001-1 μM B[j]A and 0.1-5 μM B[a]P on pChk1 and γH2AX. In (C) 706 
densitometric analysis of pChk1 and γH2AX. Densitometric analysis of DBC was previously 707 
published in Jarvis et al., 2013. Non-linear curve fit, sigmoidal dose response, n=4. 708 
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Table 1. Information of the air PM samples collected in Stockholm and Limeira.  709 
Name Abbreviation Sampling period Duration 
(hours) 
Sampled air 
(m3) 
Total PAH
(pg/m3) 
B[a]P  
(pg/m3, n=3) 
B[j]A 
(pg/m3, n=3)
Total PM 
(mg) 
Stockholm 1 STO1 Jan 18-21, 2013 71 5141 4440 ± 138 289 ± 4 12.7 ± 0.2 36.8 
Stockholm 2 STO2 Sep 10-17, 2013 168 12265 351 ± 4.1 17.3 (SD<0.02) 1.57 ± 0.07 91.3 
Stockholm 3 STO3 Dec 10-17, 2013 167 11034 793 ± 7.1 49.5 ± 0.5 3.14 ± 0.15 60.3 
Limeira 1 LMR1 Jul 12, 2010 24 2352 7958 ± 158 560 ± 10 19.6 ± 0.8 263 
Limeira 2 LMR2 Jul 19, 2010 24 2441 10693 ± 297 899 ± 17 30.2 ± 0.7 234 
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Table 2. Contribution of B[j]A levels to the excess lifetime cancer cases from exposure to air 711 
PM. Based on B[a]Peq levels and the WHO unit risk value of 8.7×10-5 ng/m3 B[a]P.4  712 
Air PM Excess lifetime cancer cases / 100 000 people 
 B[a]P B[a]Peq excl. B[j]A B[a]Peq incl. B[j]Aa 
   RPF of B[j]A = 10b RPF of B[j]A = 30c RPF of B[j]A = 60d 
STO1 2.5 11.3 + 1.1 + 3.4 + 6.7 
STO2 0.15 0.77 + 0.14 + 0.41 + 0.82 
STO3 0.43 2.3 + 0.3 + 0.9 + 1.7 
LMR1 4.9 16.2 + 1.7 + 5.1 + 10.2 
LMR2 7.8 22.7 + 2.6 + 7.9 + 15.7 
a increase in cancer cases compared to B[a]Peq excl. B[j]A; b from16,40-41, c our fold induction data for γH2AX 713 
(Table S2), d from15 714 
 715 
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